Catestatin increases the expression of anti-apoptotic and pro-angiogenetic factors in the post-ischemic hypertrophied heart of SHR.
BACKGROUND:In the presence of comorbidities the effectiveness of many cardioprotective strategies is blunted. The goal of this study was to assess in a hypertensive rat model if the early reperfusion with anti-hypertensive and pro-angiogenic Chromogranin A-derived peptide, Catestatin (CST:hCgA352-37...
Main Authors: | Claudia Penna, Teresa Pasqua, Daniela Amelio, Maria-Giulia Perrelli, Carmelina Angotti, Francesca Tullio, Sushil K Mahata, Bruno Tota, Pasquale Pagliaro, Maria C Cerra, Tommaso Angelone |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4123866?pdf=render |
Similar Items
-
Retraction: Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR.
by: PLOS ONE Editors
Published: (2021-01-01) -
Catestatin as a Target for Treatment of Inflammatory Diseases
by: Elke M. Muntjewerff, et al.
Published: (2018-10-01) -
Obligatory Role for Endothelial Heparan Sulphate Proteoglycans and Caveolae Internalization in Catestatin-Dependent eNOS Activation
by: Sara Fornero, et al.
Published: (2014-01-01) -
Catestatin improves insulin sensitivity by attenuating endoplasmic reticulum stress: In vivo and in silico validation
by: Abhijit Dasgupta, et al.
Published: (2020-01-01) -
P.026 A PIVOTAL ROLE OF THE ANTI-ANGIOGENETIC FACTOR THROMBOSPONDIN-2 IN THE PROGRESSION OF CARDIAC HYPERTROPHY TO FAILURE.
by: S. Heymans*, et al.
Published: (2007-06-01)